Klaudia Farkas (Tamás Molnár)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Cross Sectional

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Top Venues

Expert opinion on biological therapy

Scandinavian journal of gastroenterology

Expert opinion on drug safety

United European gastroenterology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Bernadett Farkas, Emese Ivány, Anita Bálint, Péter Bacsur, Tamás Molnár, Klaudia Farkas
Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum. Inflammatory bowel diseases (2024)
Orsolya Inczefi, Hélène Eutamene, Fanny Placide, Valérie Tondereau, Petra Pallagi, Mária Bagyánszki, Nikolett Bódi, Nikolett Gémes, Gábor Szebeni, Klaudia Farkas, Vassilia Theodorou, Richárd Róka
Translational evaluation of Gelsectan ® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea. United European gastroenterology journal (2024)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Patricia Sarlos, Alexander Bikar, Nelli Farkas, Tamás Resál, Zoltán Szepes, Klaudia Farkas, Ferenc Nagy, Áron Vincze, Pal Miheller, Tamás Molnár
Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey. Expert opinion on biological therapy (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas
Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases. Journal of Crohn's & colitis (2023)
Jasmijn A M Sleutjes, Jeanine E Roeters van Lennep, Eric Boersma, Luis A Menchen, Matthias Laudes, Klaudia Farkas, Tamás Molnár, Nicholas Alexander Kennedy, Marieke J Pierik, Christien J van der Woude, Annemarie C de Vries
Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels. Alimentary pharmacology & therapeutics 54 (8) (2021)
Laurent Goessens, Jean-Frédéric Colombel, An Outtier, Marc Ferrante, Joao Sabino, Ciaran Judge, Reza Saeidi, Louise Rabbitt, Alessandro Armuzzi, Eugeni Domènech, George Michalopoulos, Anneline Cremer, Francisco Javier García-Alonso, Tamas Molnar, Konstantinos Karmiris, Krisztina Gecse, Joep Van Oostrom, Mark Löwenberg, Klaudia Farkas, Raja Atreya, Davide Giuseppe Ribaldone, Christian Philipp Selinger, Frank Hoentjen, Benoit Bihin, Shaji Sebastian, null null, Jean-François Rahier
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study. United European gastroenterology journal (2021)
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Csontos, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert opinion on biological therapy 21 (4) (2021)
Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh, Péter Takács, Andras Borsi, Anita Bálint, Klaudia Farkas, Ágnes Csontos, Péter L Lakatos, Tamás Szamosi, Tamás Molnár
Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016. Expert opinion on biological therapy 20 (4) (2020)
Mariann Rutka, Renáta Bor, Tamás Molnár, Klaudia Farkas, Daniella Pigniczki, Anna Fábián, Márk Györffy, Anita Bálint, Ágnes Csontos, Mónika Szücs, László Tiszlavicz, Ferenc Nagy, Zoltán Szepes
Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015 Turkish journal of medical sciences 50 (4) (2020)
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szücs, Árpád Füredi, László Czakó, Mariann Rutka, Klaudia Farkas, Tamás Molnár, Ágnes Csontos, Anita Bálint, Kata Judit Szántó, Sándor Hamar, László Kaizer, László Tiszlavicz, Zoltán Szepes
Slow-pull technique yields better quality smears: prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine-needle aspiration. Scandinavian journal of gastroenterology 55 (11) (2020)
Renáta Bor, Anna Fábián, Mária Matuz, Zoltán Szepes, Klaudia Farkas, Pál Miheller, Tamás Szamosi, Áron Vincze, Mariann Rutka, Kata Judit Szántó, Anita Bálint, Ferenc Nagy, Ágnes Csontos, Tibor Tóth, Ferenc Zsigmond, Judit Bajor, Katalin Müllner, Lilla Lakner, Mária Papp, Ágnes Salamon, Gábor Horváth, Krisztina Sarang, Eszter Schäfer, Patrícia Sarlós, Károly Palatka, Tamás Molnár
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study. Expert opinion on biological therapy 20 (2) (2019)
Daniella Pigniczki, Mariann Rutka, Klaudia Farkas, Tamas Molnar
Lupus-like reactions in patients with inflammatory bowel disease: a little bit different data from another center. Scandinavian journal of gastroenterology 54 (12) (2019)
Renáta Bor, Anna Fábián, Klaudia Farkas, Tamás Molnár, Zoltán Szepes
Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data. Expert opinion on biological therapy 18 (7) (2018)
Anita Bálint, Mariann Rutka, Martin Kolar, Dana Duricova, Veronika Hruba, Katarina Mitrova, Karin Malickova, Milan Lukas, Zoltán Szepes, Ferenc Nagy, Károly Palatka, Szilvia Lovas, Zsuzsanna Végh, Zsuzsanna Kürti, Ágnes Csontos, Pál Miheller, Tibor Nyári, Renáta Bor, Anna Fábián, Kata Judit Szántó, Péter L Lakatos, Tamás Molnár, Klaudia Farkas
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort. Expert opinion on biological therapy 18 (11) (2018)
Anna Fábián, Mariann Rutka, Tamás Ferenci, Renáta Bor, Anita Bálint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Zsuzsanna Lénárt, Ferenc Nagy, Zoltán Szepes, Tamás Molnár
The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders. Gastroenterology research and practice 2018 (2018)
Kata Szántó, Tibor Nyári, Anita Bálint, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Klaudia Farkas
Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. PloS one 13 (7) (2018)
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Csontos, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L Lakatos, Zoltán Szepes, Tamás Molnár
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center. Expert opinion on biological therapy 17 (11) (2017)
Mariann Rutka, Renáta Bor, Anita Bálint, Anna Fábián, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Mónika Szűcs, László Tiszlavicz, Klaudia Farkas, Tamás Molnár
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum. Mediators of inflammation 2016 (2016)